NewsAI-assisted

SIGA Technologies Strengthens Leadership with General Jack Keane’s Appointment

SIGA welcomes General Jack Keane to its board, reinforcing its commitment to national security and biodefense.

Mrudula Kulkarni
By Mrudula Kulkarni
Managing Editor - Pharma Now
Mar 19, 2025Updated Jun 26, 2025 · 2 min read
SIGA Technologies Strengthens Leadership with General Jack Keane’s Appointment
freepik.com
AI-assisted reporting
Reviewed by Mrudula Kulkarni, Managing Editor - Pharma Now

SIGA Technologies, Inc. has appointed retired four-star General John "Jack" Keane to its Board of Directors, bringing decades of leadership and national security expertise to the company. With a distinguished military career spanning 37 years, including serving as acting Chief of Staff and Vice Chief of Staff of the U.S. Army, General Keane has played a pivotal role in shaping U.S. defense strategies. Beyond his military service, he has advised global leaders, testified before Congress, and contributed expert analysis on foreign policy. His appointment strengthens SIGA’s mission to expand its antiviral TPOXX and enhance national biodefense preparedness.

Diem Nguyen, CEO of SIGA Technologies, praised General Keane’s addition, emphasizing his unparalleled insights into global security challenges. General Keane expressed enthusiasm for the role, citing his lifelong commitment to strategic readiness and national defense. As SIGA continues its work supplying antiviral solutions to the U.S. and international partners, his guidance is expected to play a key role in advancing the company’s strategic initiatives.

TopicsNews
Mrudula Kulkarni
Written by
Mrudula Kulkarni
Managing Editor - Pharma Now

My international experience as a researcher in Taiwan for three years has equipped me with a global perspective, enabling me to create content that resonates with an international audience.



Discussion

Loading discussion…

More from Pharma News

All stories →